American Journal of Psychiatry Audio

225 afleveringen
October 2026: The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions
01-10-2026 | 25 Min.Dr. Charles Conway (Washington University School of Medicine, St. Louis) joins the podcast to discuss the RECOVER trial, a RCT that looked at vagus nerve stimulation and its effects on profoundly treatment resistant depression. Following that, AJP Editor-in-Chief Dr. Ned Kalin is joined by the October issue guest editor, Dr. William McDonald (Emory University, Atlanta) to discuss the rest of the October issue, which focuses on neuromodulation and precision therapeutics.
00:42 Conway interview
02:34 Quality of life
05:13 Ethical considerations of a sham arm in this population
07:00 Timing and VNS treatment
08:03 Clinical implications
09:02 Limitations
10:12 Further research
11:30 McDonald and Kalin interview
13:50 Song et al.
14:08 Li et al.
15:44 Donnery et al.
16:38 Valiengo et al.
17:28 Rush
20:03 Mahmoudi
22:37 Conway et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.orgSeptember 2026: Circadian Rhythm Stabilization App to Prevent Mood Episode Recurrence in Patients With Mood Disorders: A Multicenter, Double-Blind, Sham-Controlled, Randomized Clinical Trial
01-09-2026 | 29 Min.Dr. Heon-Jeong Lee (Korea University, Seoul) joins AJP Audio to discuss an app-based intervention designed to help individuals with mood disorders regulate their circadian rhythms to prevent recurrence of mood episodes. Afterwards, Dr. Ned Kalin will join us again to discuss the rest of the September issue of the Journal, which takes a close look at clinical treatment.
00:44 Findings
01:42 How the app works
03:05 Differences between the app and traditional lifestyle advice
04:14 Ethics surrounding shame treatment arms
05:43 Broader applicability of the intervention
06:50 Limitations
08:19 Immediate clinical implications
09:33 Further research
10:08 Kalin interview
10:27 Yeom et al.
16:02 Schacht et al.
20:31 Khosravani et al.
24:52 Peterson et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.orgAugust 2026: Cognitive, Electrophysiological, and Behavioral Presentation of First-Episode Psychosis With or Without Cannabis Exposure
01-08-2026 | 33 Min.Dr. Deepak Cyril D'Souza (Yale University School of Medicine) joins the podcast to discuss a study looking at two cohorts of patients hospitalized with first instances of psychosis, one with cannabis exposure and one without. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the August issue of the Journal, which takes a look at issues surrounding schizophrenia spectrum disorder, from the clinical to basic science.
00:40 D'Souza interview
02:38 Subtyping and schizophrenia spectrum disorder
04:19 Relapse and long-term implications for cannabis induced psychosis
05:43 Improvements in cognition
08:03 Differences between the groups
09:26 Greater access and greater potency of cannabis products
11:29 Further research
13:45 Kalin interview
13:59 D'Souza et al.
21:34 Forsyth et al.
27:36 Enwright et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.orgJuly 2026: Social Determinants of Health in Psychiatric Disorders: Exciting Opportunities for Biopsychosocial Research and Clinical Care
01-07-2026 | 37 Min.Dr. Dilip Jeste (Social Determinants of Health Network, La Jolla, CA) joins the podcast to discuss how social determinants of health interact with treatment for psychiatric disorders. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin once again puts the rest of the July issue into context.
00:31 Impacts of social determinants of health on psychiatric disorders, research, and clinical care
04:43 Health related social needs versus social determinants of health
08:47 Loneliness as a risk factor
12:36 A clinician's role in societal factors
14:47 Mechanistic understandings social determinants and the exposome
18:17 Further research
22:25 Kalin interview
22:30 Jeste and Gyan
23:33 Blundell et al.
28:03 Yang et al.
32:20 Van der Meer et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.orgJune 2026: Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
01-06-2026 | 29 Min.Dr. Jason Tucciarone and Dr. Alan Schatzberg (Stanford University, Stanford, CA) join AJP Audio to discuss the use of low-dose buprenorphine as an adjunctive therapy to extend the anti-suicidal effects of ketamine treatment in patients with major depressive disorder and suicidal ideation. AJP Editor-in-Chief Dr. Ned Kalin joins to discuss the rest of the June issue of the Journal, which takes a close look at issues surrounding suicide and severe depression.
01:20 Tucciarone and Schatzberg interview
03:36 Disparity between effects on suicidal ideation and antidepressant ratings
05:36 Ethics of placebo and ketamine in patients with suicidal ideation
08:28 Immediate clinical implications
11:40 Limitations
14:10 Further research
16:19 Kalin interview
16:24 Tucciarone et al.
20:39 Rovers et al.
24:30 Jelen et al.
Transcript
Board-certified psychiatrists, if you're seeking meaningful inpatient work with real clinical autonomy, consider becoming the Clinical Director for a 16-bed behavioral health hospital in Fergus Falls or Bemidji, Minnesota. You'll lead a supportive interdisciplinary team, enjoy predictable work-life balance, and have opportunities for teaching and mentorship without RVU pressure or third-party billing. Learn more on APA's Career Center, JobCentral, by searching Direct Care and Treatment – State of Minnesota.
Direct Care and Treatment – State of Minnesota: bit.ly/DCTClinicalDirector
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.org
Luister naar American Journal of Psychiatry Audio, The Mel Robbins’s Podcast en vele andere podcasts van over de hele wereld met de radio.net-app

Ontvang de gratis radio.net app
- Zenders en podcasts om te bookmarken
- Streamen via Wi-Fi of Bluetooth
- Ondersteunt Carplay & Android Auto
- Veel andere app-functies
Ontvang de gratis radio.net app
- Zenders en podcasts om te bookmarken
- Streamen via Wi-Fi of Bluetooth
- Ondersteunt Carplay & Android Auto
- Veel andere app-functies


American Journal of Psychiatry Audio
download de app,
luisteren.















